Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Branston

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Mucosal Immunology|May 8, 2009
Science funding in low- and middle-income countries: the example of vaccine researchR H Branston, J A G Whitworth
Current Gene Therapy|July 12, 2002
Herpes simplex virus vectors for the nervous systemC E Lilley, R H Branston, R S Coffin
Journal of Virology|May 24, 2000
Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous systemJ A Palmer, R H Branston, C E Lilley, et al.
Gene Therapy|February 22, 2003
ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour propertiesB L Liu, M Robinson, Z-Q Han, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Mucosal Immunology|May 8, 2009
Science funding in low- and middle-income countries: the example of vaccine researchR H Branston, J A G Whitworth
Current Gene Therapy|July 12, 2002
Herpes simplex virus vectors for the nervous systemC E Lilley, R H Branston, R S Coffin
Journal of Virology|May 24, 2000
Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous systemJ A Palmer, R H Branston, C E Lilley, et al.
Gene Therapy|February 22, 2003
ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour propertiesB L Liu, M Robinson, Z-Q Han, et al.
Pageof 1